<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163198">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02003196</url>
  </required_header>
  <id_info>
    <org_study_id>RC13_0228</org_study_id>
    <nct_id>NCT02003196</nct_id>
  </id_info>
  <brief_title>Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)</brief_title>
  <acronym>IBIS-VIRUS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Morbidity and mortality of ICU patients is increased by the development of a
      &quot;immunosuppression&quot; systemic (IS). This IS develops in the early hours of hospitalization
      and is responsible for severe infections, including viral reactivations (Cytomegalovirus or
      Herpes Simplex Virus). Viral reactivation was associated with increased morbidity and
      mortality in intensive care units. In clinical practice, they are searched at the onset of
      organ failure or unexplained fever. The investigators wish to conduct this research in the
      stroke patients to assess the predictive power of these viral reactivations on the duration
      of mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PCR for herpes simplex virus in blood and in tracheal aspirate (Day-1, Day-7 and Day-15) -
      clinicians are blinded to the results PCR for Cytomegalovirus in blood and in tracheal
      aspirate (Day-1, Day-7 and Day-15) - clinicians are blinded to the results
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Ventilatory-free days at day 90</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacterial hospital acquiered infection</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>organ failure</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalisation length of stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days and 90 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Brain Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Acute brain injury (trauma, subarachnoid haemorrhage, stroke, infection) with Glasgow
             Coma Scale &lt;= 12

          -  Age between 18 and 75 years
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalisation in intensive care unit

          -  Acute brain injury (trauma, subarachnoid haemorrhage, stroke, infection) with Glasgow
             Coma Scale &lt;= 12

          -  Age between 18 and 75 years

          -  Mechanical ventilation &gt; 24 hours

        Exclusion Criteria:

          -  encephalopathy post anoxy

          -  active cancer

          -  Immunosuppresseur treatment

          -  pregnancy

          -  history of autoimmune disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim Asehnoune, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Asehnoune Karim</last_name>
    <email>karim.asehnoune@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karim Asehnoune, Pr</last_name>
      <email>karim.asehnoune@chu-nantes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Delphine Flattres Duchaussoy</last_name>
      <email>delphine.flattresduchaussoy@chu-nantes.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>December 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain injury</keyword>
  <keyword>virus</keyword>
  <keyword>immunosuppression</keyword>
  <keyword>mechanical ventilation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
